Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2009 - 2026)
Teva Pharmaceutical Industries' Asset Utilization Ratio was 0.43 in Q2 2026, up 2.4% from 0.42 a year earlier and up 0.9% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
From Q1 2009 onward, Teva Pharmaceutical Industries has reported Asset Utilization Ratio for 70 quarters.
- Asset Utilization Ratio has now increased for eight consecutive years.
- In earlier years, Asset Utilization Ratio was 0.40 in FY2024 (+10.3%), 0.36 in FY2023 (+11.3%), 0.33 in FY2022 (+0.8%) and 0.32 in FY2021 (+4.8%).
- The Q2 2026 figure marks the highest quarterly Asset Utilization Ratio since Q1 2015.
- Compared with a year earlier, Asset Utilization Ratio has increased for 16 straight quarters, with growth averaging 7.4% over the last eight quarters.
- The best year-over-year quarter for Asset Utilization Ratio over five years was Q1 2025 (growth of 15.2%); the worst was Q2 2022 (a decline of 0.2%).
- Per Business Quant data, TEVA's Asset Utilization Ratio in the three quarters before Q2 2026 was 0.43 (Q1 2026), 0.43 (Q4 2025) and 0.42 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn | 0.43 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.43 |
| Mar 31, 2026 | 0.43 |
| Dec 31, 2025 | 0.43 |
| Sep 30, 2025 | 0.42 |
| Jun 30, 2025 | 0.42 |
| Mar 31, 2025 | 0.43 |
| Dec 31, 2024 | 0.41 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.39 |
| Mar 31, 2024 | 0.37 |
| Dec 31, 2023 | 0.37 |
| Sep 30, 2023 | 0.36 |
| Jun 30, 2023 | 0.35 |
| Mar 31, 2023 | 0.34 |
| Dec 31, 2022 | 0.34 |
| Sep 30, 2022 | 0.34 |
| Jun 30, 2022 | 0.33 |
| Mar 31, 2022 | 0.33 |
| Dec 31, 2021 | 0.33 |
| Sep 30, 2021 | 0.33 |
API Access
Teva Pharmaceutical Industries Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();